Overview

ACZ885 in Type 1 Diabetes Mellitus

Status:
Withdrawn

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study will assess the safety and efficacy of ACZ885 on stimulated C-peptide during a mixed meal test in patients with newly-diagnosed type 1 diabetes mellitus.

Phase:

Phase 2

Details

Lead Sponsor:

Novartis Pharmaceuticals